Promising Penny Stocks To Watch In May 2025

In This Article:

As the U.S. market navigates a landscape marked by ongoing tariff discussions and fluctuating indices, investors are keenly watching for opportunities amid uncertainty. Penny stocks, despite their somewhat dated nomenclature, remain a compelling area of interest due to their potential for growth at accessible price points. When these smaller or newer companies showcase strong financial health and solid fundamentals, they can offer unique opportunities that might not be as prevalent in larger firms.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

Safe Bulkers (NYSE:SB)

$3.42

$355.42M

★★★★☆☆

IDenta (OTCPK:IDTA)

$0.7497

$1.31M

★★★★★★

Tuya (NYSE:TUYA)

$2.41

$1.38B

★★★★★★

Kiora Pharmaceuticals (NasdaqCM:KPRX)

$3.12

$10.05M

★★★★★★

Flexible Solutions International (NYSEAM:FSI)

$3.93

$45.53M

★★★★★★

Imperial Petroleum (NasdaqCM:IMPP)

$2.71

$90.51M

★★★★★★

BAB (OTCPK:BABB)

$0.83

$6.1M

★★★★★★

Dingdong (Cayman) (NYSE:DDL)

$2.54

$533.62M

★★★★★★

Lifetime Brands (NasdaqGS:LCUT)

$3.00

$73.74M

★★★★★☆

CBAK Energy Technology (NasdaqCM:CBAT)

$0.8595

$75.82M

★★★★★☆

Click here to see the full list of 757 stocks from our US Penny Stocks screener.

Let's dive into some prime choices out of the screener.

Repay Holdings

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Repay Holdings Corporation is a payments technology company offering integrated electronic payment processing solutions for consumers and businesses in the United States, with a market cap of approximately $358.19 million.

Operations: Repay Holdings generates revenue through its Business Payments segment, which accounts for $52.92 million, and its Consumer Payments segment, contributing $280.97 million.

Market Cap: $358.19M

Repay Holdings, with a market cap of US$358.19 million, is navigating the challenges typical of penny stocks. Despite being unprofitable, it has a positive cash flow and sufficient runway for over three years. The company reported annual sales of US$313.04 million but faced a net loss of US$10.16 million in 2024, showing improvement from the previous year's larger losses. Recent executive changes and strategic reviews may impact its trajectory as it explores options to enhance shareholder value. While debt levels have increased, short-term assets cover immediate liabilities, offering some financial stability amidst its volatility concerns.

NasdaqCM:RPAY Financial Position Analysis as at May 2025
NasdaqCM:RPAY Financial Position Analysis as at May 2025

BARK

Simply Wall St Financial Health Rating: ★★★★★☆